$5.87
11.33% yesterday
Nasdaq, Apr 03, 10:00 pm CET
ISIN
US28531P1030
Symbol
ECOR

electroCore, Inc. Stock price

$5.87
-8.84 60.10% 1M
-1.52 20.57% 6M
-10.34 63.79% YTD
-0.49 7.70% 1Y
-2.91 33.15% 3Y
-9.56 61.97% 5Y
-291.58 98.03% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.75 11.33%
ISIN
US28531P1030
Symbol
ECOR
Sector

Key metrics

Market capitalization $42.22m
Enterprise Value $34.14m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.36
P/S ratio (TTM) P/S ratio 1.68
P/B ratio (TTM) P/B ratio 5.18
Revenue growth (TTM) Revenue growth 57.09%
Revenue (TTM) Revenue $25.18m
EBIT (operating result TTM) EBIT $-12.16m
Free Cash Flow (TTM) Free Cash Flow $-6.95m
Cash position $12.22m
EPS (TTM) EPS $-1.70
P/E forward negative
P/S forward 1.33
EV/Sales forward 1.07
Short interest 10.28%
Show more

Is electroCore, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

electroCore, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a electroCore, Inc. forecast:

5x Buy
100%

Analyst Opinions

5 Analysts have issued a electroCore, Inc. forecast:

Buy
100%

Financial data from electroCore, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
25 25
57% 57%
100%
- Direct Costs 3.79 3.79
35% 35%
15%
21 21
62% 62%
85%
- Selling and Administrative Expenses 30 30
18% 18%
119%
- Research and Development Expense 2.36 2.36
56% 56%
9%
-11 -11
38% 38%
-43%
- Depreciation and Amortization 1.26 1.26
0% 0%
5%
EBIT (Operating Income) EBIT -12 -12
35% 35%
-48%
Net Profit -12 -12
37% 37%
-47%

In millions USD.

Don't miss a Thing! We will send you all news about electroCore, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

electroCore, Inc. Stock News

Neutral
GlobeNewsWire
one day ago
ROCKAWAY, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has been recognized by the Financial Times as one of “The Americas' Fastest Growing Companies 2025.
Neutral
GlobeNewsWire
3 days ago
ROCKAWAY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham Virtual Healthcare Conference taking place virtually on April 10, 2025.
Neutral
GlobeNewsWire
4 days ago
ROCKAWAY, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that electroCore has received a new Federal Supply Schedule (FSS) contract, with an effective date of June 15, 2025 and running through June 14, 2030.
More electroCore, Inc. News

Company Profile

electroCore, Inc. is a commercial stage medical device company, which engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats, and Thomas J. Errico in September 2005 and is headquartered in Basking Ridge, NJ.

Head office United States
CEO Daniel Goldberger
Employees 73
Founded 2005
Website www.electrocore.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today